Vol 80, No 2 (2022)
Editorial
Published online: 2022-01-26
Adult congenital heart disease and the Coronavirus Disease 2019: how to deal with uncertainty
Abstract
Not available
References
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020; 323(13): 1239–1242.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054–1062.
- Ruperti-Repilado FJ, Tobler D, Greutmann M, et al. EPOCH. Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts. Open Heart. 2021; 8(1): e001455.
- Diller GP, Gatzoulis MA, Broberg CS, et al. Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease. Eur Heart J. 2021; 42(19): 1858–1865.
- Lewis MJ, Anderson BR, Fremed M, et al. CUIMC Pediatric/Adult Congenital Heart Research Collaborative ‡. Impact of coronavirus disease 2019 (COVID-19) on patients with congenital heart disease across the lifespan: the experience of an Academic Congenital Heart Disease center in New York City. J Am Heart Assoc. 2020; 9(23): e017580.
- Schwerzmann M, Ruperti-Repilado F, Baumgartner H, et al. Clinical outcome of COVID-19 in patients with adult congenital heart disease. Heart. 2021; 107(15): 1226–1232.
- Broberg CS, Kovacs AH, Sadeghi S, et al. COVID-19 in Adults With Congenital Heart Disease. J Am Coll Cardiol. 2021; 77(13): 1644–1655.
- Lipczyńska M, Kowalik E, Kumor M, et al. Predictors of COVID-19 outcomes in adult congenital heart disease patients - anatomy versus function. Kardiol Pol. 2021 [Epub ahead of print].
